15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Kanzhun Ltd ADR, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $18.00 to $19.00, so the covering firms are broadly aligned. The average target of $18.50 sits 18% above the current $15.72. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.14 next quarter toward $9.80 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Kanzhun Ltd ADR.
As of Jul, 4 of 4 firms rate BZ a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BZ EPS & revenue forecast
EPS · NEXT QUARTER
$2.14
Range $1.82 – $2.29 · 6 analysts · -1% YoY
Next period, 6 analysts expect Kanzhun Ltd ADR to earn $2.14 a share (range $1.82 – $2.29), versus $2.16 a year earlier. Full-year consensus is $8.73, growing to $9.80 the year after.
REVENUE · NEXT QUARTER
$2.5B
Range $2.4B – $2.5B · 6 analysts · +14% YoY
Revenue is expected to reach $2.5B (range $2.4B – $2.5B), +13.8% year-over-year. Full-year consensus is $9.3B, rising to $10.5B next year.
Top analysts covering Kanzhun Ltd ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BZ.
#1
Jiong Shao
Barclays · Rank #43
Buy
$19.00+20.9% to target
Overall win rate
51%
+ Follow
#2
RZ
Robin Zhu
Bernstein
Buy
$18.00+14.5% to target
Coverage
—
+ Follow
#3
TZ
Timothy Zhao
Goldman Sachs
Buy
$28.00+78.1% to target
Coverage
—
+ Follow
#4
WX
Wei Xiong
UBS
Buy
$26.00+65.4% to target
Coverage
—
+ Follow
#5
BG
Brian Gong
Citigroup
Buy
$26.00+65.4% to target
Coverage
—
+ Follow
BZ stock forecast FAQ
What is BZ's average 12-month price target?+
The 2 analysts with a live target average $18.50 for Kanzhun Ltd ADR over the next 12 months, ranging from a $19.00 high to a $18.00 low.
Is BZ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BZ?+
The Street-high target is $19.00 (Barclays), and the Street-low is $18.00 (Bernstein). The average of all 2 active targets is $18.50.
How many Wall Street analysts cover BZ?+
4 analysts have an active rating on Kanzhun Ltd ADR, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BZ?+
Among analysts who currently cover BZ, Jiong Shao of Barclays has the strongest overall Quantellect track record (Rank #43). Their current call is Buy with a $19.00 target.
What is Kanzhun Ltd ADR's projected EPS for next quarter?+
The consensus estimate is $2.14 per share (range $1.82 – $2.29) across 6 analysts. Full-year EPS is projected at $8.73, rising to $9.80 the following year.
How much revenue is Kanzhun Ltd ADR expected to report next quarter?+
Consensus revenue is $2.5B (range $2.4B – $2.5B). Full-year revenue is projected at $9.3B, growing to $10.5B next year.
Have analysts been upgrading or downgrading BZ lately?+
As of Jul, 4 of 4 firms rate BZ a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
